Related Experiment Video
Updated: Sep 28, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Vancomycin-resistant Staphylococcus aureus--Pennsylvania, 2002
Abstract:
Staphylococcus aureus is one of the most common causes of hospital- and community-acquired infections. Since the recognition of vancomycin-resistant enterococci in 1988, the emergence of vancomycin-resistant S. aureus (VRSA) (minimum inhibitory concentration [MIC] > or = 32 microg/mL) has been anticipated. The transfer of the genetic element containing the vanA vancomycin resistance gene from Enterococcus faecalis to S. aureus was demonstrated in the laboratory in 1992; the first clinical infection with VRSA was reported in July 2002. This report describes the second documented clinical isolate of VRSA from a patient.
Insights
The second case of vancomycin-resistant Staphylococcus aureus (VRSA) infection is reported. This emergence highlights the growing threat of antibiotic resistance in bacterial pathogens.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Staphylococcus aureus is a significant cause of healthcare-associated and community-acquired infections.
- The emergence of vancomycin-resistant Staphylococcus aureus (VRSA) has been a growing concern since vancomycin-resistant enterococci were identified.
- Laboratory studies demonstrated the potential for vancomycin resistance gene transfer to S. aureus.
Observation:
- The first clinical VRSA infection was reported in July 2002.
- This report details the second documented clinical isolate of VRSA from a patient.
Findings:
- The study presents the second confirmed clinical case of VRSA.
- This finding underscores the reality of VRSA infections in clinical settings.
Implications:
- The increasing prevalence of VRSA poses a significant challenge to public health.
- Effective infection control and antimicrobial stewardship are crucial to combat the spread of VRSA.
- Further research is needed to understand the epidemiology and treatment of VRSA infections.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Staphylococcal Skin Infections
Acute Pyelonephritis II: Diagnostic Studies and Management
Antibiotic Selection